Ignite Creation Date:
2025-12-24 @ 5:06 PM
Ignite Modification Date:
2026-03-25 @ 4:25 PM
Study NCT ID:
NCT01815450
Status:
COMPLETED
Last Update Posted:
2015-02-02
First Post:
2013-03-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
BLI1100-202: BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris
Sponsor:
Braintree Laboratories
Organization:
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2015-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to compare the safety and efficacy of BLI1100 formulations to placebo for the treatment of moderate to severe acne vulgaris.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: